Key Acquisitions and AI Are Turning This Veteran Back Into a Competitor 

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Despite facing declining revenue after demand dwindles for its COVID-related treatments, the company remains a confident contender in the race to reshape healthcare. And some of its most recent actions show how Pfizer doing just that.

The post Key Acquisitions and AI Are Turning This Veteran Back Into a Competitor  appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.